Video

Investment & Incentives: Who Will Lead The Charge?

Source: Drug Discovery Online

An audience question sparks discussion on investor hesitancy and economic frameworks. Zaher outlines opportunities in rare diseases, high-failure-rate domains, and pandemic preparedness. He argues NAMS can democratize drug development globally, while Shashi emphasizes reproducibility and validation as keys to scaling adoption.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests: